Safety study of a new painkiller compared to bupivacaine
Treatments studied
Part of Pain clinical trials.
This study tests a new long-acting pain medication called HYR-PB21 against a standard local anesthetic (bupivacaine). It is for healthy volunteers to check safety and how the drug behaves in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult, aged 18 to 50.
- Your body mass index (BMI) must be between 18 and 32, and you must weigh at least 50 kg (about 110 lbs).
- You must be a non-smoker and have not used recreational drugs or marijuana in the past.
- You must not have bleeding disorders, blood clotting problems, or certain medical conditions like heart, liver, or kidney disease.
- You must agree to use effective contraception (if applicable) and not donate blood or plasma for a period of time before and after the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called HRS-2129 for managing pain after abdominal surgery. It is for adults who will have moderate to severe pain after their operation, and aims to see if the drug can help control that pain safely.
This study tests a new experimental drug (HW243040) in healthy volunteers to see if it is safe and how the body handles it. It includes pain testing to measure how the drug works on pain.
This study tests an experimental drug called (2R,6R)-HNK given through an IV to see if it can reduce pain caused by heat in healthy volunteers. It will help researchers learn if this drug could be a future pain reliever.
This trial tests a long-acting pain medication (bupivacaine liposome injection) to control pain after lung surgery done through a small cut. It may help you feel more comfortable and reduce the need for other pain medicines.
This study tests a new medicine called KR25102 to see if it is safe and how the body handles it. It may help develop a treatment for pain.
This trial compares two pain relievers, hydromorphone and nalbuphine, given through a patient-controlled pump after cesarean section. It aims to find which provides better pain control with fewer side effects.
Hear when a new Postoperative Analgesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.